Blood flow interplays with elastin: Collagen and MMP: TIMP ratios to maintain healthy vascular structure and function

Vascular Health and Risk Management

Volumn 6, Issue 1, 2010, Pages 215-228

  Basu, Poulami ^a   Sen, Utpal ^a   Tyagi, Neetu ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Atherosclerosis; Passive stretch tension relationship; Vascular remodeling

Indexed keywords

COLLAGEN; COLLAGEN TYPE 4; COLLAGENASE 3; ELASTIN; GELATIN; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ARCH; AORTA FLOW; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; BLOOD FLOWMETRY; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL FUNCTION; BLOOD VESSEL WALL; CAROTID ARTERY FLOW; CONTROLLED STUDY; ENZYME ACTIVITY; FEMORAL ARTERY FLOW; FEMORAL VEIN; HISTOLOGY; IN VIVO STUDY; INFERIOR CAVA VEIN; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; ULTRASOUND; VENOUS PRESSURE; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; AORTA; CAROTID ARTERY, COMMON; ELASTIN; FEMORAL ARTERY; FEMORAL VEIN; MALE; MATRIX METALLOPROTEINASES; RATS; REGIONAL BLOOD FLOW; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 77950855113     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Greenwald SE. Ageing of the conduit arteries. J Pathol. 2007;211(2): 157-172.
2. Milewicz DM, Urban Z, Boyd C. Genetic disorders of the elastic fiber system. Matrix Biol. 2000;19(6):471-480.
3. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995;75(3):519-560.
4. Apter JT. Correlation of visco-elastic properties with microscopic structure of large arteries. IV. Thermal responses of collagen, elastin, smooth muscle, and intact arteries. Circ Res. 1996;21(6):901-918.
5. Harkness ML, Harkness RD, McDonald DA. The collagen and elastin content of the arterial wall in the dog. Proc R Soc Lond B Biol Sci. 1957;146(925):541-551.
6. Looker T, Berry CL. The growth and development of the rat aorta. II. Changes in nucleic acid and scleroprotein content. J Anat. 1972;113(Pt 1):17-34.
7. Rucklidge GJ, Milne G, McGaw BA, Milne E, Robins SP. Turnover rates of different collagen types measured by isotope ratio mass spectrometery. Biochim Biophys Acta. 1992;11:1156-1157.
8. Tyagi SC, Simon SR. Regulation of neutrophil elastase activity by elastin-derived peptide. J Biol Chem. 1993;268(22):16513-16518.
9. Kumar M, Tyagi N, Moshai KS, et al. Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery. Neurochem Int. 2008;53(6-8):214-219.
10. Garcia-Moll X. Inflammatory and anti-inflammatory markers in acute coronary syndromes. Ready for use in the clinical setting? Rev Esp Cardiol. 2005;58(6):615-617.
11. Libby P, Lee RT. Matrix matters. Circulation. 2000;102(16): 1874-1876.
12. Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient-Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98(2A):2H-15H.
13. Tardif JC, Heinonen T, Orloff D, Lippy P. Vascular biomarkers and surrogates in cardiovascular disease. Circulation. 2006;113(25): 2936-2942.
14. Hanaoka M, Droma Y, Ota M, Katsuyama Y, Kubo K. Polymorphisms of human vascular endothelial growth factor gene in high-altitude pulmonary oedema susceptible subjects. Respirology. 2009;14(1): 46-52.
15. Ota R, Kutihara C, Tsou TL, et al. Roles of matrix metalloproteinases in flow-induced outward vascular remodeling. J Cereb Blood Flow Metab. 2009.
16. Nagase HR, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69(3): 562-573.
17. Janssens S, Lijnen HR. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models? Cardiovasc Res. 2006;69(3):585-594.
18. Bobik A, Tkachuk V. Metalloproteinases and plasminogen activators in vessel remodeling. Curr Hypertens Rep. 2003;5(6):466-472.
19. Bouvet C, Gilbert LA, Girardot D, de Bois D, Moreau P. Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition. Hypertension. 2005;45(3):432-437.
20. Chun TH, Sabeh F, Ota I, et al. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol. 2004;167(4):757-767.
21. Galli A, Svegliati-Baroni G, Ceni E, et al. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2- mediated mechanism. Hepatology. 2005;41(5):1074-1084.
22. Hayden MR, Sowers JR, Tyagi SC. The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: The matrix preloaded. Cardiovasc Diabetol. 2005;4(1):9.
23. He JZ, Ho JJ, Gingerich S, Courtman DW, Marsden PA, Ward ME. Induction of matrix metalloproteinase-2 enhances systemic arterial contraction after hypoxia. Am J Physiol Heart Circ Physiol. 2007;292(1):H684-H693.
24. Lehoux S, Lemarie CA, Esposito B, Lijnen HR, Tedgui A. Pressure- induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation. 2004;109(8):1041-1047.
25. Li Z, Froelich J, Galis ZS, Lakatta EG. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension. 1999;33(1):116-123.
26. Watts SW, Rondelli C, Thalaki K, et al. Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol. 2007;292(5): H2438-H2448.
27. Beaudeux JL, Giral P, Bruckert E, Foglietti MJ, Chapman MJ. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives. Clin Chem Lab Med. 2004;42(2):121-131.
28. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 2008;75(2):346-359.
29. Brew KD, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta. 2000;1477(1-2):67-83.
30. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth- promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci. 1994;107(Pt 9):2373-2379.
31. Van Hinsbergh VW. Arteriosclerosis. Impairment of cellular interactions in the arterial wall. Ann N Y Acad Sci. 1992;673:321-330.
32. Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases: A review of their structure and role in acute coronary syndrome. Cardiovasc Res. 2003;59(4):812-823.
33. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138(5 Pt 2):S419-S420.
34. Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev. 2005;85(1):1-31.
35. Vink A, Schoneweld AH, Poppen M, de Kleijn DP, Borst C, Pasterkamp G. Morphometric and immunohistochemical character- ization of the intimal layer throughout the arterial system of elderly humans. J Anat. 2002;200(Pt 1):97-103.
36. Sen U, Basu P, Abe OA, et al. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am J Physiol Renal Physiol. 2009;297(2):F410-F419.
37. Yasmin, McEniery CM, O'Shaughnessy KM, et al. Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals. Arterioscler Thromb Vasc Biol. 2006;26(8):1799-1805.
38. Langille BL, Bendeck MP, Keeley FW. Adaptations of carotid arteries of young and mature rabbits to reduced carotid blood flow. Am J Physiol. 1989;256(4 Pt 2):H931-H939.
39. Langille BL, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science. 1986;231(4736):405-407.